Bridgeway Capital Management’s Abiomed Inc ABMD Stock Holding History

Bridgeway Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,000	Closed	-$1.19M	–	1381
2019 Q4	$1.19M	Hold	7,000	–	–	0.02%	703
2019 Q3	$1.25M	Hold	7,000	–	–	0.02%	661
2019 Q2	$1.82M	Sell	7,000 -3,200	-31%	-$849K	0.02%	563
2019 Q1	$2.91M	Sell	10,200 -3,100	-23%	-$1.03M	0.04%	391
2018 Q4	$4.32M	Sell	13,300 -19,100	-59%	-$6.63M	0.06%	241
2018 Q3	$14.6M	Hold	32,400	–	–	0.14%	140
2018 Q2	$13.3M	Sell	32,400 -15,010	-32%	-$5.44M	0.13%	143
2018 Q1	$13.8M	Buy	47,410 +15,010	+46%	+$3.8M	0.15%	127
2017 Q4	$6.07M	Buy	+32,400	New	+$6.05M	0.07%	244
2016 Q3	–	Sell	-4,900	Closed	-$536K	–	1496
2016 Q2	$536K	Hold	4,900	–	–	0.01%	1019
2016 Q1	$465K	Hold	4,900	–	–	0.01%	1088
2015 Q4	$442K	Hold	4,900	–	–	0.01%	1099
2015 Q3	$455K	Sell	4,900 -3,625	-43%	-$319K	0.01%	1080
2015 Q2	$560K	Sell	8,525 -800	-9%	-$53.2K	0.01%	1023
2015 Q1	$667K	Buy	9,325 +425	+5%	+$23.1K	0.01%	970
2014 Q4	$339K	Buy	+8,900	New	+$281K	0.01%	1192

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bridgeway Capital Management's ABMD Position: Q1 2020 in Review

Bridgeway Capital Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 7,000 shares — an estimated $1.19M sold.

Bridgeway Capital Management first reported a position in ABMD in Q4 2014 and held it in 16 quarters. The position peaked at $14.6M in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

Bridgeway Capital Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
Bridgeway Capital Management sold 7,000 Abiomed Inc shares in Q1 2020, an estimated $1.19M.
Bridgeway Capital Management first reported a position in Abiomed Inc in Q4 2014 and held it in 16 quarters.
Bridgeway Capital Management's Abiomed Inc position peaked at $14.6M in Q3 2018.
412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.